Antibacterial medical implant surface
US-10610621-B2 · Apr 7, 2020 · US
US11116877B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11116877-B2 |
| Application number | US-201815927428-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 21, 2018 |
| Priority date | Mar 21, 2017 |
| Publication date | Sep 14, 2021 |
| Grant date | Sep 14, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Aspects include methods of fabricating antibacterial surfaces for medical implant devices including patterning a photoresist layer on a silicon substrate and etching the silicon to generate a plurality of nanopillars. Aspects also include removing the photoresist layer from the structure and coating the plurality of nanopillars with a biocompatible film. Aspects also include a system for preventing bacterial infection associated with medical implants including a thin silicon film including a plurality of nanopillars.
Opening claim text (preview).
What is claimed is: 1. A system for preventing bacterial infection associated with medical implant procedures, comprising: a silicon film comprising a controlled pattern of a plurality of nanopillars that have been etched into a silicon base, the plurality of nanopillars spaced apart at regular intervals comprising a pitch of 400 to 450 nm, the plurality of nanopillars formed by: patterning a photoresist to expose a surface of the silicon base; depositing a metal layer on a top surface of the photoresist and on the exposed surface of the silicon base; removing the photoresist to lift off portions of the metal layer on the top surface of the photoresist; and recessing portions of the silicon base under remaining portions of the metal layer using a metal-assisted chemical etch, wherein the metal-assisted chemical etch is locally restricted to an interface between the remaining portions of the metal layer and the exposed surface of the silicon base; wherein each of the plurality of nanopillars has a top pillar diameter within a range from about 1 nanometer to about 200 nanometers; and wherein each of the plurality of nanopillars has a same height. 2. The system according to claim 1 , further comprising a biocompatible film. 3. The system according to claim 2 , wherein the biocompatible film coats a surface of the plurality of nanopillars. 4. The system according to claim 2 , wherein the biocompatible film comprises titanium. 5. The system according to claim 2 , wherein the biocompatible film forms a conformal coating on the plurality of nanopillars. 6. The system according to claim 2 , wherein the biocompatible film comprises a conductive metal. 7. The system according to claim 6 , wherein the conductive metal film comprises platinum, silver, aluminum, nickel, titanium, or alloys thereof. 8. The system according to claim 2 , wherein the biocompatible film comprises aluminum oxide, hydroxyapatite, silicon dioxide, titanium carbide, titanium nitride, titanium dioxide, zirconium dioxide, calcium phosphate, chromium nitride, collagen, chitosan, cellulose or cellulose derivatives, poly-/-lactic acid (PLLA), poly(ε-caprolactone) (PCL), poly(lactide-co-glycolide) (PLGA), poly(ether imide) (PEI), poly(1,3-trimethylene carbonate) (PTMC), poly(styrene sulfonate) (PSS), or combinations thereof. 9. The system according to claim 2 , wherein the biocompatible film comprises nitrides, oxides, metallic oxides, metallic hydroxides, nanoporous inorganic coatings, natural polymers, synthetic polymers, or a combinations thereof. 10. The system according to claim 2 , wherein the biocompatible film comprises titanium nitride. 11. The system according to claim 1 , wherein the silicon base has a thickness of less than or equal to about 100 micrometers. 12. The system according to claim 1 , wherein the silicon film has a thickness of about 1 micron to about 100 microns. 13. The system according to claim 1 , wherein the silicon film is flexible. 14. The system according to claim 1 , wherein the silicon film is adhered to a surface of a medical implant device. 15. The system according to claim 14 , wherein the medical implant device allows human cell adherence or growth. 16. The system according to claim 1 , wherein the silicon film has a thickness of less than 50 micrometers.
Processes for functionalising a surface, e.g. provide the surface with specific mechanical, chemical or biological properties · CPC title
Manufacture or treatment of substrate-free structures, i.e. not connected to any support · CPC title
of static structures · CPC title
Other specific inorganic materials not covered by A61L27/303 - A61L27/32 · CPC title
Biologically active materials, e.g. therapeutic substances {(A61L31/047 takes precedence)} · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.